Bio-Rad Laboratories, Inc.
BIO
$238.68
-$2.34-0.97%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.66B | 1.66B | 1.62B | 1.62B | 1.65B |
| Total Receivables | 438.40M | 465.60M | 473.04M | 455.31M | 459.61M |
| Inventory | 790.10M | 760.00M | 804.28M | 803.69M | 783.37M |
| Prepaid Expenses | 125.40M | 122.60M | 133.23M | 153.01M | 142.74M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.30M | 17.60M | 22.62M | 28.14M | 29.54M |
| Total Current Assets | 3.04B | 3.03B | 3.06B | 3.06B | 3.06B |
|
|
|||||
| Total Current Assets | 3.04B | 3.03B | 3.06B | 3.06B | 3.06B |
| Net Property, Plant & Equipment | 681.70M | 688.60M | 719.17M | 715.24M | 711.28M |
| Long-term Investments | 414.60M | 410.50M | 415.10M | 412.12M | 412.82M |
| Goodwill | 414.60M | 410.50M | 415.10M | 412.12M | 412.82M |
| Total Other Intangibles | 296.10M | 293.60M | 307.33M | 307.09M | 313.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 105.00M | 103.50M | 105.12M | 99.79M | 94.37M |
| Total Assets | 9.53B | 9.36B | 10.60B | 9.69B | 12.61B |
|
|
|||||
| Total Accounts Payable | 137.90M | 122.30M | 122.19M | 126.69M | 102.75M |
| Total Accrued Expenses | 157.40M | 124.20M | 146.02M | 132.46M | 146.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 42.50M | 42.90M | 44.10M | 42.00M | 40.53M |
| Total Finance Division Other Current Liabilities | 168.80M | 178.40M | 185.64M | 185.81M | 176.39M |
| Total Other Current Liabilities | 168.80M | 178.40M | 185.64M | 185.81M | 176.39M |
| Total Current Liabilities | 506.60M | 467.80M | 497.94M | 486.96M | 466.15M |
|
|
|||||
| Total Current Liabilities | 506.60M | 467.80M | 497.94M | 486.96M | 466.15M |
| Long-Term Debt | 1.19B | 1.19B | 1.19B | 1.19B | 1.19B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 135.30M | 140.60M | 153.22M | 160.39M | 169.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.01B | 995.20M | 1.27B | 1.07B | 1.73B |
| Total Liabilities | 2.85B | 2.79B | 3.12B | 2.91B | 3.56B |
|
|
|||||
| Common Stock & APIC | 475.70M | 463.20M | 448.33M | 474.73M | 462.63M |
| Retained Earnings | 7.48B | 7.42B | 8.13B | 7.48B | 9.64B |
| Treasury Stock & Other | -1.28B | -1.31B | -1.09B | -1.18B | -1.06B |
| Total Common Equity | 6.68B | 6.57B | 7.49B | 6.78B | 9.05B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.68B | 6.57B | 7.49B | 6.78B | 9.05B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.68B | 6.57B | 7.49B | 6.78B | 9.05B |
|
|
|||||